Ionis Report PositiveData from Phase2 Study of AKCEA-APO(a)-LRx
IONS: Ionis Pharmaceuticals, Inc.
2018-09-24 07:00:00
Akcea and Ionis Report Positive Data from Phase 2 Study of AKCEA-APO(a)-LRx
2018-09-24 07:00:00
Akcea and Ionis Report Positive Data from Phase 2 Study of AKCEA-APO(a)-LRx